Sarcopenia risks highlighted for chronic kidney disease patients

Medical experts are highlighting the critical link between chronic kidney disease (CKD) and sarcopenia, a condition characterized by muscle loss. While elderly populations generally face a 7% to 10% prevalence of sarcopenia, those with CKD face a significantly higher risk of 15% to 20%.

Managing nutrition for CKD patients presents a challenge: high protein intake can strain kidney function by increasing nitrogenous waste, yet insufficient protein accelerates muscle wasting. Clinical recommendations suggest that patients in stages 3 to 5 may benefit from a low-protein diet supplemented with keto-analogues of amino acids to support muscle synthesis without increasing kidney load. Combining this with resistance and aerobic exercise is recommended to maintain muscle mass.

To address these growing concerns in an aging society, the 3rd International Symposium on Sarcopenia, Cachexia, and Frailty will be held in Taipei. The event will bring together experts from the UK, Japan, South Korea, and Singapore to discuss prevention and treatment strategies. Experts warn that muscle strength often declines before visible muscle mass loss, and individuals should watch for signs such as reduced appetite, slower walking speeds, and shortness of breath.